Literature DB >> 17655962

Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices.

Uwe Gbureck1, Elke Vorndran, Frank A Müller, Jake E Barralet.   

Abstract

The aim of this study was to investigate the adsorption and desorption kinetics of antibiotics to microporous bioceramics fabricated by a novel low temperature 3D powder direct printing process. The adsorption of vancomycin, ofloxacin and tetracycline onto hydroxyapatite, brushite and monetite showed a linear correlation with the drug concentration in the immersion solution, whereas a non-linear relationship was found between the immersion time and the amount of adsorbed drug. Differences in the total amount of adsorbed drugs were correlated to the specific surface areas of the matrices, which varied between 2.4-13.1 m(2)/g. Normalised drug loadings were found to be in the range of 1.5-1.8 mg/m(2) for vancomycin and ofloxacin, whereas higher loads of up to 5-7 mg/m(2) were obtained for tetracycline. Vancomycin and ofloxacin were rapidly released into PBS buffer within 1-2 days, while tetracycline showed a much slower release rate of approximately 25% after 5 days of immersion. Additional polymer impregnation of the drug loaded matrix with PLA/PGA polymer solutions enabled the release kinetics to be delayed such that sustained release was achieved in polymer ceramic biocomposites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655962     DOI: 10.1016/j.jconrel.2007.06.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  23 in total

Review 1.  An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems.

Authors:  Kapilkumar Vithani; Alvaro Goyanes; Vincent Jannin; Abdul W Basit; Simon Gaisford; Ben J Boyd
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

2.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 3.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

Review 4.  3D Printing of Calcium Phosphate Ceramics for Bone Tissue Engineering and Drug Delivery.

Authors:  Ryan Trombetta; Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Ann Biomed Eng       Date:  2016-06-20       Impact factor: 3.934

Review 5.  Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.

Authors:  Mohamed A Alhnan; Tochukwu C Okwuosa; Muzna Sadia; Ka-Wai Wan; Waqar Ahmed; Basel Arafat
Journal:  Pharm Res       Date:  2016-05-18       Impact factor: 4.200

6.  3D powder printed tetracalcium phosphate scaffold with phytic acid binder: fabrication, microstructure and in situ X-Ray tomography analysis of compressive failure.

Authors:  Sourav Mandal; Susanne Meininger; Uwe Gbureck; Bikramjit Basu
Journal:  J Mater Sci Mater Med       Date:  2018-03-08       Impact factor: 3.896

7.  Additive manufacturing of biomaterials.

Authors:  Susmita Bose; Dongxu Ke; Himanshu Sahasrabudhe; Amit Bandyopadhyay
Journal:  Prog Mater Sci       Date:  2017-08-26

8.  Low temperature fabrication of spherical brushite granules by cement paste emulsion.

Authors:  Claus Moseke; Christoph Bayer; Elke Vorndran; Jake E Barralet; Jürgen Groll; Uwe Gbureck
Journal:  J Mater Sci Mater Med       Date:  2012-08-19       Impact factor: 3.896

9.  Low temperature fabrication of magnesium phosphate cement scaffolds by 3D powder printing.

Authors:  Uwe Klammert; Elke Vorndran; Tobias Reuther; Frank A Müller; Katharina Zorn; Uwe Gbureck
Journal:  J Mater Sci Mater Med       Date:  2010-08-26       Impact factor: 3.896

10.  Injectability of brushite-forming Mg-substituted and Sr-substituted alpha-TCP bone cements.

Authors:  S Pina; P M C Torres; J M F Ferreira
Journal:  J Mater Sci Mater Med       Date:  2009-10-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.